维普期刊资源整合服务平台（V6.5）

103篇 您的检索式：作者名="SCHLENK RF"

选中清除导出查看参考文献查看引证文献引用追踪共6页首页上一页第1页下一页末页 /6 跳转

	题名	作者	年代	出处	被引量
1	Deregulated expression of EVI1 defines a poor prognostic subset of MLL-rearranged acute myeloid leukemias:a study of the German-Austrian Acute Myeloid Leukemia Study Group and the Dutch-Belgian-Swiss HOVON/SAKK Cooperative Group显示文摘	Groschel S Schlenk RF Engelmann J		0，，01：	1
2	Insertion of FLT3 internal tandem duplication in the tyrosine kinase domain-1 is associated with resistance to chemotherapy and inferior outcome 显示文摘	Kayser S Schlenk RF Londono MC	2009	Blood2009，114，12：	1
3	Prognostic impact of WT1 mutations in cytogenetically normal acute myeloid leukemia:a study of the German-Austrian AML Study Group显示文摘	Gaidzik VI Schlenk RF Moschny S	2009	Blood2009，113，19：	1
4	Mutations and treatment out- come in cytogenetically normal acute myeloid leukemia显示文摘	Schlenk RF DShner K Krauter J	2008	N Engl J Med2008，358，：	1
5	DNMT3A mutations in myeloproliferative neoplasms显示文摘	Stegelmann F Bullinger L Schlenk RF	2011	Leukemia2011，25，7：	1
6	Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia显示文摘	Schlenk RF Dhner K Krauter J	2008	N Engl J Med2008，358，18：	1
7	Persistent iliac crest donor site pain:independent outcome assessment显示文摘	Herary RF Schlenk RP Sacchieri TA	2002	Neurosurgery2002，50，3：	1
8	Prognostic signifi- cance of activating FLT3 mutations in younger adults (16 to 60 years) with acute myeloid leukemia and normal cytogenetics: a study of the AML Study Group Ulm显示文摘	Frohling S Schlenk RF Breitruck J	2002	Blood2002，100，13：	1
9	Mutant nucleophosmin(NPM1)predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics:interaction with other gene mutations显示文摘	Dohner K Schlenk RF Habdank M	2005	Blood2005，106，12：	1
10	Mutant nucleophosmin ( NPM1 ) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations显示文摘	Dohner K Schlenk RF Habdank M	2005	Blood2005，106，12：	1
11	Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia显示文摘	Schlenk RF D?hner K Krauter J		0，，18：	1
12	Insertion of FLT3 internal tandem duplication in the tyrosine kinase domain-1 is associated with resistance to chemotherapy and inferior outcome显示文摘	Kayser S Schlenk RF Londono MC	2009	Blood2009，114，12：	1
13	Prognostic impact of WT1mutations in cytogenetically normal acute myeloid leukemia:a study of the German-Austrian AML Study Group显示文摘	Gaidzik VI Schlenk RF Moschny S	2009	Blood2009，113，：	1
14	Prognostic significance of acti- vating FLT3 mutations in younger adults (16 to 60 years) with acute myeloid leukemia and normal cytogenetics : a study of the AML Study Group Ulm显示文摘	Frohling S Schlenk RF Breitruck J	2002	Blood2002，100，43：	1
15	Less intense conditioning with fludyabine, cyclophosphamide, idarubicin and etoposide ( FCIE )followed by alogeneic unselected peripheral blood stem cell transplantation in elderly patients with leukemia显示文摘	Schlenk RF Hartrnarm F Hensel M	2002	Leukemia2002，16，4：	1
16	Individual pa- tient data-based meta-analysis of patients aged 16 to 60 years with core binding factor acute myeloid leuke- mia: a survey of the German Acute Myeloid Leukemia Intergroup显示文摘	Schlenk RF Benner A Krauter J	2004	J Clin Oncol2004，22，：	1
17	IDH1 and IDH2 mutations are frequent genetic alterations in acute myeloid leukemia and confer adverse prognosis in cytogenetically normal acute myeloid leukemia with NPM1 mutation without FLT3 internal tandem duplication显示文摘	Paschka P Schlenk RF Gaidzik VI		0，，22：	1
18	Secondary genetic lesions in acute myeloid leukemia with inv(16) or t(16~16) :a study of the German-Austrian AML Study Group (AMLSG) 显示文摘	Paschka P Du J Schlenk RF	2013	Blood2013，121，：	1
19	CEBPA mutations in younger adults with acute myeloid leukemia and normal cytogenetics:prognostic relevance and analysis of cooperating mutations显示文摘	Frohling S Schlenk RF Stolze I	2004	J Clin Oncol2004，22，4：	1
20	Prognostic significance of activating FLT3 mutations in youngeradults (16 to 60 years) with acute myeloid leukemia and normalcytogenetics : a study of the AML Study Group Ulm 显示文摘	FR0HLING S SCHLENK RF BREITRUCK J	2002	Blood2002，100，13：	1

返回顶部每页显示：

共6页首页上一页第1页下一页末页 /6 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示